Predicting Cancer Drug Response Using a Recommender System

preprint OA: closed CC-BY-NC-4.0
📄 Open PDF View at publisher

Abstract

Motivation As we move towards an era of precision medicine, the ability to predict patient-specific drug responses in cancer based on molecular information such as gene expression data represents both an opportunity and a challenge. In particular, methods are needed that can accommodate the high-dimensionality of data to learn interpretable models capturing drug response mechanisms, as well as providing robust predictions across datasets. Results We propose a method based on ideas from “recommender systems” (CaDRReS) that predicts cancer drug responses for unseen cell-lines/patients based on learning projections for drugs and cell-lines into a latent “pharmacogenomic” space. Comparisons with other proposed approaches for this problem based on large public datasets (CCLE, GDSC) shows that CaDRReS provides consistently good models and robust predictions even across unseen patient-derived cell-line datasets. Analysis of the pharmacogenomic spaces inferred by CaDRReS also suggests that they can be used to understand drug mechanisms, identify cellular subtypes, and further characterize drug-pathway associations. Availability Source code and datasets are available at https://github.com/CSB5/CaDRReS Contact [email protected] Supplementary information Supplementary data are available online.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-4.0